Event Name： HMIC Conference 2024
Date： Oct 22 Tue, 2024 9:30am - 5:50pm（Party 6:00pm - 7:30pm）
Type： Onsite
Venue： Nihonbashi life sciences hub 8F
〒103-0022 Tokyo, Chuo City, Nihonbashimuromachi, 1 Chome−5−5
Muromachi Chibagin Mitsui Bld. 8F（COREDO Muromachi 3）
Organiser： HMIC
Entrance Fee：Pre-Register（Part1：Free Part2：JPY 3,000）
※Tax and party included, Lunch excluded
Gold Sponsor
Life Science Insight
～How can we contribute to realizing medical innovation?～
Part 1 9:30am - 11:45am
Opening 9:30 - 9:45
Greetings
Ms. Kazumi Fujikawa,
Representative of HMIC
【A-2】9:45 - 10:45 Special Seminar
Japan Pharmaceutical Manufacturers Association's efforts for Patient and Public Involvement
- Through providing information to patients -
In the pharmaceutical field, " Patient and Public Involvement " is one of important topic recently. JPMA aims to create an environment in which innovative pharmaceuticals are delivered and used safely and appropriately by incorporating patient voices from the drug development to post-marketing steps. To achieve this goal, provisions of clinical trial and medical information are being strengthened for easy to understand to the patients and all others. The current JPMA activities related to this will be introduced.
Mr. Nakaji Shigeru
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Chairperson ／
Astellas Pharma Inc. CMO Office Strategic Operations Vice president
【A-3】10:45 - 11:45 Special Seminar
"Achieving Patient-Centered Care through 'Diversity' and 'Collective Intelligence' in Medical Innovation."
AstraZeneca, through the open innovation network "i2.JP", aims to bring together diverse partners to collaboratively develop practical and optimal solutions for issues in the healthcare field. In this presentation, he will introduce the future direction AstraZeneca should aim for, along with examples of projects that have been realized through the 'collective intelligence' of our diverse partners.
Mr. Torsten Kanisch
Commercial Excellence
Executive Officer, Vice President of Commercial Excellence
AstraZeneca K.K.
11:45 - 13:00 LUNCH TIME *Ticket does not include lunch
Part 2 1:00pm - 5:50pm
【A-4】1:00 - 2:00 Keynote Seminar
「なるほど！」から始まるくすりの価値最大化－インサイトがパラダイムシフトを加速する
医学・生命科学、デジタル技術の進歩とともに、新しい技術やアイデアが製品化され、治療法がない疾患に対しても革新的な医薬品開発が進められている。優れた新薬が広く使用され、標準治療として患者さんやご家族、社会に貢献するまでには時間が必要で、インサイトはこの変化（パラダイムシフト）を加速し、新薬の価値最大化を促進する。本講演では、製薬企業において医薬品開発や市販後活動の様々な場面でインサイトを利用した経験を踏まえ、インサイト活用推進の取り組みを紹介し、HMICへの期待を述べたい。
Mr.Taku Seriu
Apcer Life Sciences Senior Advisor to the Board ／
The instisute of Drug Development Career Promotion Representative Director
【A-5】2:00 - 2:20 Sponsor Session
Unmet Needsとは？
ー様々な立場・役割から生じるUnmet Needsとそのソリューションのご紹介ー
皆様にとってUnmet Needsとは何になりますか？各種データを持ち合わせる当社では、毎年様々なUnmet Needs分析のご依頼を頂きます。今回の講演では、皆様が課題と感じられている様々なUnmet Needsとこれら課題に対する多角的なソーリュションの一例を事例を通してご紹介させて頂きます。
%20Sunaoshi%201_edited.png)
Evaluate Japan（株）
Portfolio Strategy Adviory Division
Principal Consultant
砂押 その子 氏
【A-6】2:30 - 3:00 Invited Seminar
Insights from “Lived Experience” of patients and families with rare diseases
In the field of rare diseases, where the number of patients per disease is extremely small, there are unique challenges in conducting surveys, such as the lack of previous research and the difficulty in recruiting participants. In this presentation, the speaker will discuss how new perspectives and values can be found and utilized as insights based on some case studies of “Lived Experience” of patients and their families in this field.
Mr. Shun Emoto
Researcher
NPO ASrid
【A-7】3:00 - 4:15 Research Agencies Session
Researchers’ Challenges in the era of Healthcare Innovation
＜Facilitator＞
Kosuke Shichiku
Director, Healthcare Marketing Department, Intage Healthcare Inc.
＜Speaker, Panelist＞
Masahiko Ito, Ipsos K.K.
Takanori Norimatsu, Intage Healthcare Inc.
Aoi Kato, Seed Planning Inc.
Ryusuke Shinozaki, Social Survey Research Information Co., Ltd.
Toshimitsu Tamai, NielsenIQ Japan
Asuka Kihara, Macromill Carenet, Inc.
【A-8】16:30 -17:45 Pharma Companies Session
Healthcare Insights Evolving with Specialization and AI
＜Panelist＞
Koki Matsuda
Customer Insights & Analytics Manager
Business Innovation & Customer Excellence
Novo Nordisk Pharma Ltd.
Hiroki Kaneko
AI Marketing Manager
Commercial Effectiveness Group, Immunology Franchise
Sanofi K.K.
Kimio Isaka
Director
Marketing Strategic Group, Marketing Department, Sales & Marketing Division
Mitsubishi Tanabe Pharma Corporation
Naoto Shimizu PhD
Business Insight & Strategy Dept,
Project Lifecycle Management Unit
Chugai Pharmaceutical Company Limited
＜Facilitator＞
Takayuki Kitazawa PhD. MBA
Head, Innovative Business Creation Group, Marketing,
Neuroscience Business Unit
Takeda Pharmaceutical Company Limited
Closing
Greetings
Mr. Gaku Sasaki,
Director
Senior Executive Officer,
Seed Planning, Inc.
6:00 - 7:30
Social Gathering
